ZBAO
NASDAQ
CN
Zhibao Technology Inc. - Class A Ordinary Shares
$0.72
▼ $-0.01
(-1.37%)
Vol 64K
9
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$28.3M
P/E
16.9
ROE
17.1%
Margin
3.6%
D/E
66.94
Beta
1.54
52W
$1–$2
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2024-12-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 17.1% | 17.1% | 17.1% | 17.1% | 17.1% | 17.1% |
| P/E (TTM) | — | 17.45 | 20.80 | 19.44 | 18.15 | 16.87 |
| Net Margin | -1.0% | 3.6% | 3.6% | 3.6% | 3.6% | 3.6% |
| Gross Margin | 29.1% | 35.5% | 35.5% | 35.5% | 35.5% | 35.5% |
| D/E Ratio | 66.94 | 66.94 | 66.94 | 66.94 | 66.94 | 66.94 |
| Current Ratio | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 | 1.27 |
Key Ratios
ROA (TTM)
4.5%
P/S (TTM)
0.60
P/B
20.2
EPS (TTM)
$0.39
Rev Growth 3Y
+59.1%
52W High
$2.14
52W Low
$0.78
$0.78
52-Week Range
$2.14
How does ZBAO compare to Insurance peers?
Peer group: Micro-cap Insurance (All) · 60 companies
ZBAO valuation vs Insurance peers
P/E ratio
16.9
▲
40%
above
peers
(12.0)
vs Peers
vs Industry
Pricier
P/S ratio
0.6
▼
38%
below
peers
(1.0)
vs Peers
vs Industry
Pricier
P/B ratio
20.2
▲
1157%
above
peers
(1.6)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(1.5%)
vs Peers
vs Industry
In line
ZBAO profitability vs Insurance peers
ROE
17.1%
▲
39%
above
peers
(12.3%)
vs Peers
vs Industry
Below avg
Net margin
3.6%
▼
55%
below
peers
(8.0%)
vs Peers
vs Industry
Weak
Gross margin
35.6%
▲
0%
above
peers
(35.6%)
vs Peers
vs Industry
Weak
ROA
4.5%
▲
159%
above
peers
(1.7%)
vs Peers
vs Industry
Top tier
ZBAO financial health vs Insurance peers
D/E ratio
66.9
▲
312%
above
peers
(16.3)
vs Peers
vs Industry
High debt
Current ratio
1.3
▲
37%
above
peers
(0.9)
vs Peers
vs Industry
Below avg
Beta
1.5
▲
171%
above
peers
(0.6)
vs Peers
vs Industry
More volatile
ZBAO fundamentals radar
ZBAO
Peer median
Industry
ZBAO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ZBAO vs peers: key metrics
Related Signals
Latest News
No related news yet